Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats
- 30 November 1993
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 105 (5), 1483-1489
- https://doi.org/10.1016/0016-5085(93)90155-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Modulation of thioacetamide‐induced hepatocellular necrosis by prostaglandins is associated with novel histologic changesLiver International, 1992
- Effects of Prostaglandin E1on the Recovery of Ischemia-Induced Liver Mitochondrial Dysfunction in Rats with CirrhosisScandinavian Journal of Gastroenterology, 1991
- Gastric mucosal prostaglandin E2 levels in cirrhosis and portal hypertensionJournal of Hepatology, 1990
- The gastric mucosa in portal hypertensionJournal of Hepatology, 1989
- Estimation of collagen content of liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats.Journal of Histochemistry & Cytochemistry, 1989
- 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.JCI Insight, 1987
- Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosisDigestive Diseases and Sciences, 1987
- Cytoprotective effect of prostaglandins on isolated rat liver cellsLiver International, 1985
- 16,16-Dimethyl-PGE2 Protection Against α — Napthy lisothiocy anate - Induced Experimental Cholangitis in the RatHepatology, 1984
- Reduction by cytoprotective agents of ethanol-induced damage to the rat gastric mucosa: a correlated morphological and physiological studyCanadian Journal of Physiology and Pharmacology, 1982